Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
Evaluation of the diagnostic and prognostic efficacy of nuclear magnetic resonance imaging in patients with acute sensorineural hearing loss or in patients suffering from probable or definite MD. The neuroradiological and audiological evaluation are held on in the same day in order to better clarify the radiological and clinical correlates.
- EligibilityCriteria: Inclusion Criteria:  age > 18 years  onset of symptoms less than 10 days no previous episodes of sudden ipsilateral hearing loss no systemic or oral corticosteroid intake in the previous month Informed consent  Exclusion Criteria:  Current or previous otopathy and/or labyrinth diseases of known cause Known nervous system disorders Patients with renal insufficiency (creatinine level > 1.5 mg/dL) Patients with pacemakers, other metal implants, claustrophobics and known psychiatric disorders Pregnant patients Materials and methods Diagnostic evaluation at enrollment (T0) Audiological or ENT examination Liminal tonal audiometric exam, vocal, impedance measurement, otoacoustic emissions, video-impulse test, oVEMPS, cVEMPS, stabilometry Hematological tests: complete blood count, ESR, PCR, creatininemia, CMV IgM, EBV IgM, ANA, glycemia, study of predisposing genetic factors - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Patients suffering from acute sudden hearing loss and Meniere's disease according to the criteria of the American Academy of Otolaryngology. - SamplingMethod: Probability Sample